Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Expert Opinion on Drug Safety|December 25, 2019
The safety of ixekizumab in psoriasis drug therapyLluís PuigInternational Journal of Molecular Sciences|January 4, 2018
Cardiometabolic Comorbidities in Psoriasis and Psoriatic ArthritisLluís PuigExpert Review of Clinical Immunology|February 7, 2017
The role of IL 23 in the treatment of psoriasisLluís PuigGiornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 15, 2016
The role of biologics in the treatment of moderate-to-severe plaque psoriasisLluís PuigExpert Review of Clinical Immunology|March 29, 2019
Guselkumab for the treatment of adults with moderate to severe plaque psoriasisLluís PuigCurrent Problems in Dermatology|November 14, 2017
Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and OthersLluís PuigExpert Review of Clinical Immunology|March 18, 2015
Systemic methotrexate for the treatment of psoriasisOriol Yélamos, Lluís PuigInternational Journal of Molecular Sciences|August 10, 2024
A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment TargetsLluís Rusiñol, Lluís PuigImmunotherapy|January 12, 2021
IL-13 antagonists in the treatment of atopic dermatitisCarla Tubau, Lluís PuigTherapeutic Advances in Chronic Disease|August 19, 2021
Dual inhibition of IL-17A and IL-17F in psoriatic diseaseHelena Iznardo, Lluís PuigPageof 17